IP Library Granted Patent US 7,465,539
Granted Patent B1
US 7,465,539 · App. 08/483,535 · Granted Dec 16, 2008

DNA polymerases with enhanced length of primer extension

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,465,539
App. No.
08/483,535
Granted
Dec 16, 2008
Kind
B1
Abstract

A formulation of thermostable or other DNA polymerases comprising (a) at least one thermostable or other DNA polymerase which lacks 3′-exonuclease activity, and (b) at least one thermostable DNA polymerase exhibiting 3′-exonuclease activity, wherein the ratio of (a) to (b) is greater than 1 to 1. Also provided is an improved method for enzymatic extension of DNA strands, especially while, but not limited to, amplifying nucleic acid sequences by polymerase chain reaction wherein the above formulation is made and used to catalyze primer extension, are also provided.

Claims (22)

1. A method for amplifying a nucleic acid, comprising:

preparing a composition comprising a DNA polymerase comprising at least one thermostable DNA polymerase which lacks 3′-exonuclease activity, at least one thermostable DNA polymerase which exhibits 3′-exonuclease activity, and a nucleic acid comprising a sequence to be amplified, wherein the ratio of DNA polymerase activity of the at least one thermostable DNA polymerase which lack 3′-exonuclease activity to DNA polymerase activity of the at least one thermostable DNA polymerase which exhibits 3′-exonuclease activity from about 100:1 up to about 600:1; and

subjecting the composition to conditions effective for amplifying the nucleic acid sequence,

wherein the nucleic acid sequence to be amplified is a nucleic acid sequence 6 kb or more in length.

2. A method as set forth in claim 1 wherein the nucleic acid sequence to be amplified is a nucleic acid sequence 8.4 kb or more in length.

3. A method as set forth in claim 1 wherein the nucleic acid sequence to be amplified is a nucleic acid sequence 15 kb or more in length.

4. A method as set forth in claim 1 wherein the composition further comprises an oligonucleotide primer or primers, wherein at least one primer is itself a product of a PCR amplification.

5. A method for amplifying a nucleic acid, comprising:

preparing a composition comprising a DNA polymerase comprising at least one thermostable DNA polymerase which lacks 3′-exonuclease activity, at least one thermostable DNA polymerase which exhibits 3′-exonuclease activity, and a nucleic acid comprising a sequence to be amplified, wherein the ratio of DNA polymerase activity of the at least one thermostable DNA polymerase which lack 3′-exonuclease activity to DNA polymerase activity of the at least one thermostable DNA polymerase which exhibits 3′-exonuclease activity exceeds 1 to 1; and wherein the nucleic acid sequence to be amplified is a nucleic acid sequence 6 kb or more in length wherein the conditions effective for amplifying the nucleic acid sequence comprise conditions effective for denaturing the nucleic acid sequence, and wherein the denaturing has a duration of less than 20 seconds.

6. A method as set forth in claim 5 wherein the denaturing has a duration of less than 5 seconds.

7. A method of amplifying a polynucleotide sequence, said method comprising: the steps of mixing a composition with a synthesis primer and a synthesis template, said composition comprising:

(a) a first DNA polymerase, wherein said first polymerase possesses 3′-5′ exonuclease activity selected from the group consisting of Archaebacterial DNA polymerases and

(b) a second DNA polymerase, wherein said second polymerase lacks 3′-5′ exonuclease activity selected from the group consisting of thermostable DNA polymerases lacking 3′-5′ exonuclease activity; wherein the ratio of DNA polymerase activity of the first DNA polymerase to the DNA polymerase activity of the second DNA polymerase is from about 1:100 up to about 1:600.

8. A method according to claim 7 , wherein said first DNA polymerase is Pyrococcus furiosus DNA polymerase.

9. A method according to claim 7 , wherein said second DNA polymerase is a Thermus aquaticus DNA polymerase selected from the group consisting of wild-type Thermus aquaticus DNA polymerase and N-terminal deleted forms of the same enzyme.

10. A method according to claim 7 , wherein said second DNA polymerase is Thermus aquaticus DNA polymerase.

11. A method according to claim 9 , wherein said Thermus aquaticus DNA polymerase is Klentaq-278 DNA polymerase.

12. A method according to claim 8 , wherein said second DNA polymerase is Thermus aquaticus DNA polymerase.

13. A method according to claim 8 , wherein said second DNA polymerase is Klentaq-278 DNA polymerase.

14. A method according to claim 7 , wherein said first DNA polymerase comprises Vent DNA polymerase.

15. A method according to claim 14 , wherein said second DNA polymerase is Thermus aquaticus DNA polymerase.

16. A method according to claim 14 , wherein said second DNA polymerase is Klentaq-278 DNA polymerase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2003
From: TAKARA HOLDINGS, INC. (FORMERLY TAKARA SHUZO CO. LTD.)
To: TAKARA BIO INC.
Reel/Frame 014781/0841 →
JAPANESE CERTIFIED COMPLETE CHRONOLOGICAL RECORD AND CERTIFIED ENGLISH TRANSLATION Recorded Nov 7, 2002
From: TAKARA SHUZO CO., LTD.
To: TAKARA BIO INC.
Reel/Frame 013456/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 1996
From: BARNES, WAYNE M., PH.D.
To: TAKARA SHUZO CO., LTD.
Reel/Frame 008285/0321 →